Concepedia

Author

Michael Hejna

Medical University of Vienna

Also Known As

Hejna M., M H Hejna, M H L Hejna, M Hejna, M. HEJNA, M. Hejna, M.H. Hejna, M.H.L Hejna, M.H.L. Hejna, MICHAEL HEJNA

139

Publications

5.2K

Citations

36

H-Index

64

Concepts

All Affiliations

Medical University of ViennaUniversity of ViennaVienna General HospitalLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVAComprehensive Cancer Center Vienna
MH

About

Michael Hejna is an author at Medical University of Vienna specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

28

1.5K

2

Health Sciences

6

6

714

3

Cell Biology

4

4

149

4

Allergy

1

1

64

5

Endocrinology

1

1

12

Michael Hejna

×

65

Publications

4.1K

Citations

33

H-Index

YearCitations

Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Manuela Schmidinger, Christoph Zielinski, Ursula Vogl,

Journal of Clinical Oncology

2008

613

Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment

Wolfgang J. Köstler, Michael Hejna, C. Wenzel,

CA A Cancer Journal for Clinicians

2001

364

Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality

Noémi Pávó, Markus Raderer, Martin Hülsmann,

Heart

2015

267

Endoscopic Ultrasound Guided Therapy of Benign and Malignant Biliary Obstruction: A Case Series

Andreas Püspök, Friedrich Lomoschitz, Clemens Dejaco,

The American Journal of Gastroenterology

2005

183

The impact of hemoglobin levels on fatigue and quality of life in cancer patients

Bernhard Holzner, Georg Kemmler, Richard Greil,

Annals of Oncology

2002

171

Association between Helicobacter pylori Infection and Pancreatic Cancer

Markus Raderer, Friedrich Wrba, Gabriela Kornek,

Oncology

1997

166

Monitoring of Serum Her-2/<b> <i>neu</i> </b> Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer

Wolfgang J. Köstler, Barbara Schwab, Christian F. Singer,

Clinical Cancer Research

2004

144

Two Consecutive Phase II Studies of 5-Fluorouracil/Leucovorin/Mitomycin C and of Gemcitabine in Patients with Advanced Biliary Cancer

Markus Raderer, Michael Hejna, Julia Valencak,

Oncology

1999

131

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable

Ursula Vogl, Harald Zehetgruber, Martin Dominkus,

British Journal of Cancer

2006

100

Combined Irinotecan and Oxaliplatin Plus Granulocyte Colony-Stimulating Factor in Patients With Advanced Fluoropyrimidine/Leucovorin-Pretreated Colorectal Cancer

Werner Scheithauer, Gabriela Kornek, Markus Raderer,

Journal of Clinical Oncology

1999

90

Page 1